Talkspace(US:TALK)2025-10-30 13:30Financial Data and Key Metrics Changes - Total net revenue reached $59.4 million, representing a 25% year-over-year increase and a 9% sequential increase [20] - Adjusted EBITDA was $5 million, reflecting a 111% year-over-year growth [24] - Adjusted gross profit was $24.6 million, up 13% year-over-year, with a gross margin of 41.5% compared to 43.1% in the prior quarter [22] Business Line Data and Key Metrics Changes - Payer revenue grew 42% year-over-year to $45.5 million, with over 432,000 payer sessions completed, up 12% sequentially and 37% year-over-year [20][21] - Direct to Enterprise (DTE) revenue was $9.3 million, down 1% year-over-year and 2% sequentially, attributed to delays in material launches [21] - Consumer revenue from out-of-pocket payments totaled $4.6 million, a slight increase from $4.4 million last quarter but a decline from $6 million a year ago [21] Market Data and Key Metrics Changes - Active payer members grew 8% sequentially and 29% year-over-year, reaching over 120,000, the highest quarterly figure since the company's inception [3][20] - The psychiatry business saw a 46% increase in initial session volume, with a nearly 50% growth in the psychiatry provider network from Q2 [5] Company Strategy and Development Direction - The company is focusing on optimizing the internal referral funnel between therapy and psychiatry services to drive growth [6] - The acquisition of WISDO Health aims to enhance peer-to-peer community support and coaching, particularly for Medicare patients [6][7] - The company is leveraging AI-driven tactics to optimize marketing and improve the patient journey [4][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the payer business's growth trajectory, driven by strategic product investments and efficient marketing [20][25] - The company narrowed its full-year guidance for 2025, expecting revenue between $226 million and $230 million, reflecting a year-over-year growth of 20% to 23% [25][26] - Management highlighted the importance of clinical oversight and real-time risk determination in their AI model, setting a new standard for therapeutic efficacy and user safety [14][15] Other Important Information - The company ended the quarter with $96 million in cash and equivalents, down $7 million sequentially due to share repurchase activities [24] - The company is preparing to launch a proprietary behavioral health large language model in early 2026, with various monetization strategies [16][17] Q&A Session Summary Question: How will the behavioral health large language models be integrated into the Talkspace app? - Management indicated that the integration will include clinical oversight and various monetization strategies depending on the user population, with a full market launch expected in early 2026 [31][32] Question: Can you discuss the changes made to the matching algorithm driving stronger retention? - Management noted improvements in scheduling and matching processes, which have positively impacted user retention and session bookings [35][38] Question: Are you comfortable with the number of credentialed therapists in your network? - Management expressed confidence in the current network capacity and ongoing efforts to manage and expand the therapist network [47][51] Question: What factors are driving the growth in active members and utilization? - Management attributed growth to strong marketing efficiency, payer partner collaboration, and product enhancements that improve user engagement [92][95] Question: How do you see the WISDO Health acquisition impacting the Medicare opportunity? - Management believes the integration of WISDO will significantly enhance engagement with the Medicare population, particularly through group coaching initiatives [69][74] Question: Will there be new long-term guidance provided in the future? - Management indicated that while new long-term guidance is TBD, they expect continued growth in 2026 similar to 2025 [108][110]